Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Share-based Compensation (2016 - 2024)

Historic Share-based Compensation for Sunshine Biopharma (SBFM) over the last 9 years, with Q1 2024 value amounting to $12000.0.

  • Sunshine Biopharma's Share-based Compensation changed N/A to $12000.0 in Q1 2024 from the same period last year, while for Dec 2024 it was $12000.0, marking a year-over-year change of. This contributed to the annual value of $12000.0 for FY2024, which is N/A changed from last year.
  • Per Sunshine Biopharma's latest filing, its Share-based Compensation stood at $12000.0 for Q1 2024.
  • Sunshine Biopharma's 5-year Share-based Compensation high stood at $918000.0 for Q1 2021, and its period low was $12000.0 during Q1 2024.
  • Its 3-year average for Share-based Compensation is $326666.7, with a median of $50000.0 in 2020.